
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9307094
[patent_doc_number] => 20140045768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Tight Junction Protein Modulators and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/059214
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12248
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059214
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059214 | Tight junction protein modulators and uses thereof | Oct 20, 2013 | Issued |
Array
(
[id] => 10405282
[patent_doc_number] => 20150290292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'Treatment of Depression and PTSD'
[patent_app_type] => utility
[patent_app_number] => 14/436172
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5415
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436172
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436172 | Treatment of Depression and PTSD | Oct 17, 2013 | Abandoned |
Array
(
[id] => 11464980
[patent_doc_number] => 09581603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Collagen-derived recombinant proteins with von Willebrand factor-binding activity'
[patent_app_type] => utility
[patent_app_number] => 14/436628
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10641
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436628
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436628 | Collagen-derived recombinant proteins with von Willebrand factor-binding activity | Oct 17, 2013 | Issued |
Array
(
[id] => 11389573
[patent_doc_number] => 09550805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Precipitable peptides'
[patent_app_type] => utility
[patent_app_number] => 14/052367
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 35128
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14052367
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/052367 | Precipitable peptides | Oct 10, 2013 | Issued |
Array
(
[id] => 10213916
[patent_doc_number] => 20150098908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'Biolubricant Polypeptides and Therapeutic Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/046350
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9285
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046350
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046350 | Biolubricant polypeptides and therapeutic uses thereof | Oct 3, 2013 | Issued |
Array
(
[id] => 9478221
[patent_doc_number] => 20140135682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'Super Fast-Acting Insulin Compositions'
[patent_app_type] => utility
[patent_app_number] => 13/998040
[patent_app_country] => US
[patent_app_date] => 2013-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 87620
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13998040
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/998040 | Method for control of post-prandial glucose | Sep 23, 2013 | Issued |
Array
(
[id] => 9964782
[patent_doc_number] => 09012394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Thyroglobulin quantitation by mass spectroscopy'
[patent_app_type] => utility
[patent_app_number] => 14/031678
[patent_app_country] => US
[patent_app_date] => 2013-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 10598
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14031678
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/031678 | Thyroglobulin quantitation by mass spectroscopy | Sep 18, 2013 | Issued |
Array
(
[id] => 9306102
[patent_doc_number] => 20140044775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'SYNTHETIC LUNG SURFACTANT AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/030719
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21110
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030719
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/030719 | Synthetic lung surfactant and use thereof | Sep 17, 2013 | Issued |
Array
(
[id] => 10776230
[patent_doc_number] => 20160122387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'Angiotensin Peptide and Pharmaceutical Compositions for Disease Treatment'
[patent_app_type] => utility
[patent_app_number] => 14/765248
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11289
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/765248 | Angiotensin Peptide and Pharmaceutical Compositions for Disease Treatment | Sep 12, 2013 | Abandoned |
Array
(
[id] => 10120957
[patent_doc_number] => 09155301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Antimicrobial agent comprising a cysteine component covalently bound to a substrate in particular by binding through an S-S bridge via a spacer molecule'
[patent_app_type] => utility
[patent_app_number] => 14/024162
[patent_app_country] => US
[patent_app_date] => 2013-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10795
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14024162
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/024162 | Antimicrobial agent comprising a cysteine component covalently bound to a substrate in particular by binding through an S-S bridge via a spacer molecule | Sep 10, 2013 | Issued |
Array
(
[id] => 10353573
[patent_doc_number] => 20150238578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'TREATMENT OF DISEASE USING INTER-ALPHA INHIBITOR PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/426832
[patent_app_country] => US
[patent_app_date] => 2013-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30456
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426832
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/426832 | Treatment of disease using inter-alpha inhibitor proteins | Sep 8, 2013 | Issued |
Array
(
[id] => 9552433
[patent_doc_number] => 08759484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Evaluation of copolymer diethylamide'
[patent_app_type] => utility
[patent_app_number] => 14/020566
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15701
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020566
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/020566 | Evaluation of copolymer diethylamide | Sep 5, 2013 | Issued |
Array
(
[id] => 9216311
[patent_doc_number] => 08629111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-14
[patent_title] => 'Methods of providing therapeutic effects using cyclosporin components'
[patent_app_type] => utility
[patent_app_number] => 13/967163
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6182
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967163
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967163 | Methods of providing therapeutic effects using cyclosporin components | Aug 13, 2013 | Issued |
Array
(
[id] => 9227494
[patent_doc_number] => 08633162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Methods of providing therapeutic effects using cyclosporin components'
[patent_app_type] => utility
[patent_app_number] => 13/967179
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6065
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967179
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967179 | Methods of providing therapeutic effects using cyclosporin components | Aug 13, 2013 | Issued |
Array
(
[id] => 9299820
[patent_doc_number] => 08648048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-11
[patent_title] => 'Methods of providing therapeutic effects using cyclosporin components'
[patent_app_type] => utility
[patent_app_number] => 13/967168
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6182
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967168
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967168 | Methods of providing therapeutic effects using cyclosporin components | Aug 13, 2013 | Issued |
Array
(
[id] => 9286227
[patent_doc_number] => 08642556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Methods of providing therapeutic effects using cyclosporin components'
[patent_app_type] => utility
[patent_app_number] => 13/967189
[patent_app_country] => US
[patent_app_date] => 2013-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6059
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967189
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/967189 | Methods of providing therapeutic effects using cyclosporin components | Aug 13, 2013 | Issued |
Array
(
[id] => 9192021
[patent_doc_number] => 20130331336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 13/961808
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6027
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961808
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961808 | METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9389332
[patent_doc_number] => 08685930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Methods of providing therapeutic effects using cyclosporin components'
[patent_app_type] => utility
[patent_app_number] => 13/961828
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6164
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961828 | Methods of providing therapeutic effects using cyclosporin components | Aug 6, 2013 | Issued |
Array
(
[id] => 9192022
[patent_doc_number] => 20130331337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 13/961818
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6020
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961818
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961818 | METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9192023
[patent_doc_number] => 20130331338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS'
[patent_app_type] => utility
[patent_app_number] => 13/961835
[patent_app_country] => US
[patent_app_date] => 2013-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6164
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/961835 | METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS | Aug 6, 2013 | Abandoned |